Review
Published on 25 Feb 2025
Emerging roles of intratumoral microbiota: a key to novel cancer therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1506577
- 742 views
Type at least 3 characters
1,878 articles
Case Report
Published on 17 Feb 2025
Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1481244
- 716 views
- 1 citation
Review
Published on 14 Feb 2025
Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1456959
- 965 views
Original Research
Published on 14 Feb 2025
Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1544173
- 642 views
Review
Published on 12 Feb 2025
Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1527331
- 1,011 views
Original Research
Published on 12 Feb 2025
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1513622
- 1,315 views
Review
Published on 12 Feb 2025
The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1451130
- 933 views
Review
Published on 11 Feb 2025
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1542811
- 1,841 views
- 1 citation
Review
Published on 11 Feb 2025
New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1488289
- 657 views
Editorial
Published on 11 Feb 2025
Editorial: Drug repurposing for cancer treatment: current and future directions
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1550672
- 618 views
Case Report
Published on 10 Feb 2025
A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1484383
- 645 views
Mini Review
Published on 10 Feb 2025
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1548446
- 1,852 views
Review
Published on 07 Feb 2025
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1534948
- 1,225 views
Review
Published on 07 Feb 2025
Organoid models: applications and research advances in colorectal cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1432506
- 1,042 views
Mini Review
Published on 06 Feb 2025
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1534055
- 1,334 views
- 1 citation
Original Research
Published on 06 Feb 2025
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1499650
- 777 views